These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38444679)

  • 41. Retraction: lncRNA-XLOC_012370 Promotes the Development of Pancreatic Cancer and Inactivates the NF-κB Pathway Through miR-140-5p.
    Frontiers Editorial Office
    Front Oncol; 2021; 11():841478. PubMed ID: 35036363
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Retraction: MicroRNA-27 Inhibits Autophagy and Promotes Proliferation of Multiple Myeloma Cells by Targeting the NEDD4/Notch1 Axis.
    Frontiers Editorial Office
    Front Oncol; 2021; 11():840086. PubMed ID: 35036359
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Retraction: LINC01315 impairs microRNA-211-dependent DLG3 downregulation to inhibit the development of oral squamous cell carcinoma.
    Frontiers Editorial Office
    Front Oncol; 2024; 14():1378198. PubMed ID: 39026977
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Corrigendum: Successful treatment of a patient with multiple-line relapsed extensive-stage small-cell lung cancer receiving penpulimab combined with anlotinib: A case report.
    Zhang Z; Li Y; Dong Y; Li J; Zhang B; Zhang C; Cui X
    Front Oncol; 2022; 12():980842. PubMed ID: 36033531
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Retracted: The Efficacy and Safety of Anlotinib Alone and in Combination with Other Drugs in Advanced Lung Cancer: A Retrospective Cohort Study.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9789208. PubMed ID: 37946973
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Retraction: A study on expression level and nutritional status of IGFBP-2 after left neck anastomosis combined with placement of feeding nutritional applicators carrying ^(125)I particles in the treatment of esophageal cancer.
    Frontiers Editorial Office
    Front Oncol; 2024; 14():1383394. PubMed ID: 38450196
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Retraction: Prognostic influence of PD-1/PD-L1 suppressors in combination with chemotherapeutic agents for non-small cell pulmonary carcinoma: system review and meta-analysis.
    Frontiers Editorial Office
    Front Oncol; 2024; 14():1383366. PubMed ID: 38440228
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Retraction: Oncoproteins of High-Risk HPV and EBV Cooperate to Enhance Cell Motility and Invasion of Human Breast Cancer Cells
    Frontiers Editorial Office
    Front Oncol; 2021; 11():759578. PubMed ID: 34557421
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Retraction: Long noncoding RNA LOC400043 (LINC02381) inhibits gastric cancer progression through regulating Wnt signaling pathway.
    Frontiers Editorial Office
    Front Oncol; 2023; 13():1298859. PubMed ID: 38115901
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Retraction: LINC00337 Regulates KLF5 and Maintains Stem-Cell Like Traits of Cervical Cancer Cells by Modulating miR-145.
    Frontiers Editorial Office
    Front Oncol; 2021; 11():840051. PubMed ID: 35036358
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Retraction: STAT3 Promotes Invasion and Aerobic Glycolysis of Human Oral Squamous Cell Carcinoma
    Frontiers Editorial Office
    Front Oncol; 2021; 11():761874. PubMed ID: 34557422
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy and safety of anlotinib plus programmed death-1 blockade versus anlotinib monotherapy as second or further-line treatment in advanced esophageal squamous cell carcinoma: A retrospective study.
    Liu Y; Ge Q; Xu S; Li K; Liu Y
    Front Oncol; 2022; 12():942678. PubMed ID: 36059654
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Retraction: The role of LINC00284 in the development of thyroid cancer
    Frontiers Editorial Office
    Front Oncol; 2023; 13():1209909. PubMed ID: 37182166
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Retraction: LncRNA SNHG19 Promotes the Development of Non-Small Cell Lung Cancer
    Frontiers Editorial Office
    Front Oncol; 2021; 11():840907. PubMed ID: 35087764
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Retraction: LncRNA DLX6-AS1 Promotes Malignant Phenotype and Lymph Node Metastasis in Prostate Cancer by Inducing LARGE Methylation.
    Frontiers Editorial Office
    Front Oncol; 2021; 11():840152. PubMed ID: 35036360
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Retraction: The Collective Effect of MIP-3α and FL Promotes Dendritic Cell Function Within the Immune Microenvironment of Murine Liver Cancer.
    Frontiers Editorial Office
    Front Oncol; 2021; 11():744389. PubMed ID: 34497774
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Retraction: Oroxylin a Inhibits the Protection of Bone Marrow Microenvironment on CML Cells Through CXCL12/CXCR4/P-gp Signaling Pathway.
    Frontiers Editorial Office
    Front Oncol; 2020; 10():714. PubMed ID: 32373542
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Retraction: RORα Suppresses Epithelial-to-Mesenchymal Transition and Invasion in Human Gastric Cancer Cells via the Wnt/β-Catenin Pathway.
    Frontiers Editorial Office
    Front Oncol; 2020; 10():607586. PubMed ID: 33194774
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Retraction: Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Squamous Cell Carcinoma by Down-Regulating NF-kB/COX-2/VEGF Pathway.
    Frontiers Editorial Office
    Front Oncol; 2021; 11():721658. PubMed ID: 34277459
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Safety and Efficacy of Hypofractionated Stereotactic Radiotherapy with Anlotinib Targeted Therapy for Glioblastoma at the First Recurrence: A Preliminary Report.
    Guan Y; Li J; Gong X; Zhu H; Li C; Mei G; Liu X; Pan L; Dai J; Wang Y; Wang E; Liu Y; Wang X
    Brain Sci; 2022 Apr; 12(4):. PubMed ID: 35448002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.